Abstract:Cisplatin is a chemotherapeutic agent that is used extensively to treat solid tumors; however, its clinical application is limited by side effects, especially nephrotoxicity. Cisplatin-induced acute kidney injury (AKI) is characterized by DNA damage, cell-cycle arrest, and mitochondrial oxidative stress. Recent research demonstrated that 14–3-3ζ plays an important role in cancers, nerve disease, and kidney disease, although the regulatory mechanisms underlying cisplatin-induced AKI have yet to be fully elucidated. In the present study, we found that 14–3-3ζ mRNA was upregulated in human kidney organoids (GSE145085) when treated with cisplatin; subsequently, this was confirmed in experimental mice. The application of a protein interaction inhibitor for 14–3-3 (BV02) resulted in a decline in renal function, along with apoptosis, mitochondrial dysfunction, and oxidative stress in cisplatin-induced AKI. Accordingly, the knockdown of 14–3-3ζ in cisplatin-treated NRK-52E cells led to increased apoptosis, cell-cycle arrest, the production of reactive oxygen species (ROS), and lipid dysbolism. Furthermore, the blockade of 14–3-3ζ, both in vivo and in vitro , suppressed β-catenin and its nuclear translocation, thus downregulating expression of the downstream gene cyclin D1 in cisplatin-induced damage. In contrast, the overexpression of 14–3-3ζ alleviated the injury caused by cisplatin both in vivo and in vitro . Furthermore, a non-specific agonist of β-catenin, BIO, reversed the effects of 14–3-3ζ knockdown in terms of cisplatin-induced damage in NRK-52E cells by activating β-catenin. Next, we verified the direct interaction between 14 and 3-3ζ and β-catenin by CO-IP and immunofluorescence. Collectively, these findings indicate that 14–3-3ζ protects against cisplatin-induced AKI by improving mitochondrial function and the balance between proliferation and apoptosis by facilitating the nuclear translocation of β-catenin.

Mcl-1 is Downregulated in Cisplatin-Induced Apoptosis, and Proteasome Inhibitors Restore Mcl-1 and Promote Survival in Renal Tubular Epithelial Cells

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Cisplatin Induces Apoptosis of Hepatocellular Carcinoma LM3 Cells Via Down-Regulation of XIAP.

MCL-1 siRNA Reverses the Chemoresistance of Cisplatin-resistant SW480 Cells via the Pathway of Mitochondrial Apoptosis

Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1

Regulation of PUMA- α by p53 in cisplatin-induced renal cell apoptosis

Caspase-11 Promotes Cisplatin-Induced Renal Tubular Apoptosis through a Caspase-3-dependent Pathway.

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax

Mir-135A/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1

Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells.

Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity

Degradation of Mcl-1 by Beta-Trcp Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization

Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options

APOBEC-1 deletion enhances cisplatin-induced acute kidney injury

Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells

Small molecule Mcl-1 inhibitor for triple negative breast cancer therapy

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells

14–3-3ζ targets β-catenin nuclear translocation to maintain mitochondrial homeostasis and promote the balance between proliferation and apoptosis in cisplatin-induced acute kidney injury

P32, a Novel Binding Partner of Mcl-1, Positively Regulates Mitochondrial Ca(2+) Uptake and Apoptosis.